Trial · NCT02363452
Registered outcomes30
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 30
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Interferon signature | Before and after 12 months of treatment | Interferon Score |
| Secondary | Interferon signature | Month 18 | Interferon Score |
| Secondary | Adverse Events | Baseline until Month 18 | |
| Secondary | Interferon Activity Level in cerebrospinal fluid (UI/L) | Within the 12 month on treatment | |
| Secondary | Interferon Activity Level in blood (UI/L) | Within the 12 month on treatment | |
| Secondary | Interferon Activity Level in blood (UI/L) | month 18 | |
| Secondary | Interferon Protein in cerebrospinal fluid (Fg/mL) | within the 12 month on treatment | |
| Secondary | Interferon Protein in blood (FG/mL) | Within the 12 month on treatment | |
| Secondary | Interferon Protein in blood (Fg/mL) | Month 18 | |
| Secondary | Neurological assessment | Baseline | Scale for Evaluation of Movement Disorders Vineland Adaptive Behaviour Scales |
| Secondary | Neurological assessment | Month 12 | Scale for Evaluation of Movement Disorders Vineland Adaptive Behaviour Scales |
| Secondary | Neurological assessment | Month 18 | Scale for Evaluation of Movement Disorders Vineland Adaptive Behaviour Scales |
| Secondary | Radiological assessment | Baseline | MRI, CT Scan |
| Secondary | Radiological assessment | Month 12 | MRI, CT Scan |
| Secondary | dosages of abacavir | Month 1 | Blood sample |
| Secondary | dosages of zidovudine | Month 1 | Blood sample |
| Secondary | dosages of lamivudine | Month 1 | Blood sample |
| Secondary | dosages of zidovudine | Month 3 | Blood sample |
| Secondary | dosages of lamivudine | Month 3 | Blood sample |
| Secondary | dosages of abacavir | Month 3 | Blood sample |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02363452/registered